Source: Abstracts. Conference titles: American Association for Clinical Chemistry/AACC. Unidade: FCF
Subjects: POLIMORFISMO, BIOMARCADORES, ARTERIOSCLEROSE
ABNT
DUARTE, V. H. R et al. Validation of TREML4 mRNA expression and polymorphisms in blood leukocytes as potential biomarker of atherosclerosis. 2019, Anais.. Washington: AACC, 2019. . Acesso em: 10 nov. 2024.APA
Duarte, V. H. R., Manfredi, A. B., Araújo, J. N., Borges, J. B., Bastos, G. M., Hirata, M. H., et al. (2019). Validation of TREML4 mRNA expression and polymorphisms in blood leukocytes as potential biomarker of atherosclerosis. In Abstracts. Washington: AACC.NLM
Duarte VHR, Manfredi AB, Araújo JN, Borges JB, Bastos GM, Hirata MH, Hirata RDC, Luchessi AD, Silbiger VN. Validation of TREML4 mRNA expression and polymorphisms in blood leukocytes as potential biomarker of atherosclerosis. Abstracts. 2019 ;[citado 2024 nov. 10 ]Vancouver
Duarte VHR, Manfredi AB, Araújo JN, Borges JB, Bastos GM, Hirata MH, Hirata RDC, Luchessi AD, Silbiger VN. Validation of TREML4 mRNA expression and polymorphisms in blood leukocytes as potential biomarker of atherosclerosis. Abstracts. 2019 ;[citado 2024 nov. 10 ]